SCHEMBL1025970

SCHEMBL1025970

CC1=NC(c2cccc(C(=O)Nc3ccc(Cl)cc3)c2)(C2CC2)N=C1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 13/20 0.53
KCNH2 Q12809 5/20 0.53
BACE2 Q9Y5Z0 3/20 0.53
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
POLB P06746 1/20 0.44
HPGD P15428 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.43
KCNK3 O14649 1/20 0.42
APP P05067 2/20 0.41
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
NFKB1 P19838 1/20 0.40
STAT3 P40763 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932477 0.91 BACE1 (0.52) BACE1KCNH2BACE2MEN1KMT2A
SCHEMBL931202 0.82 BACE1 (0.59) BACE1KCNH2BACE2APP
SCHEMBL931182 0.80 BACE1 (0.51) BACE1KCNH2BACE2MEN1KMT2A
SCHEMBL931151 0.76 BACE1 (0.51) BACE1KCNH2BACE2MEN1KMT2A
SCHEMBL932230 0.71 BACE1 (0.59) BACE1KCNH2BACE2APP
SCHEMBL10154609 0.71 BACE1 (0.80) BACE1APP
SCHEMBL943175 0.70 BACE1 (1.00) BACE1KCNH2BACE2APP
SCHEMBL931798 0.69 BACE1 (0.58) BACE1KCNH2BACE2SMN1; SMN2ALDH1A1
SCHEMBL18926487 0.69 BACE1 (0.65) BACE1APP
SCHEMBL1355088 0.69 PTGS1 (0.67) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed